Kimberly Manhard

Kimberly Manhard has extensive experience in the biotechnology and pharmaceutical industries, currently serving as Chief Development Officer and Executive Vice President at Connect Biopharma, Inc., and as a member of various boards, including Inhibrx, Inc., Toragen, Inc., and the Fleet Science Center. Previous roles include Executive Vice President at Heron Therapeutics, overseeing drug development for oncology and pain management, and Senior Vice President at AstraZeneca, where responsibilities included regulatory affairs and development operations. Manhard also served as a consultant through Manhard Pharma Consulting and held executive positions at multiple organizations, contributing to the biopharmaceutical sector's advancement. Manhard holds a Bachelor’s Degree with a double major in Zoology and French from the University of Florida.